Ketamine-assisted psychotherapy is an emerging treatment that combines ketamine administration with psychotherapy. It is distinguished from ketamine infusion clinics by its emphasis on set and setting, the therapeutic relationship, and preparation and integration into the treatment plan. Ketamine has rapid onset and metabolism, and produces dissociative states from psycholytic to psychedelic. Its mechanisms of action involve glutamate and neuroplasticity. Risks include nausea, increased blood pressure, and potential for abuse with chronic use. Polaris Insight Center provides ketamine-assisted psychotherapy following screening, dosing, integration processes to maximize benefits and safety.
Presentation on Setting up a Ketamine Assisted Psychotherapy Practice by Veronika Gold, LMFT and Gregory Wells, PhD at Exploring Psychedelics, Ashland, Oregon, May 34-25, 2018
This check list is an early version of a self-reflection tool for students to explore clinical CBT skills they have used regularly and feel more comfortable with.
Presentation on Setting up a Ketamine Assisted Psychotherapy Practice by Veronika Gold, LMFT and Gregory Wells, PhD at Exploring Psychedelics, Ashland, Oregon, May 34-25, 2018
This check list is an early version of a self-reflection tool for students to explore clinical CBT skills they have used regularly and feel more comfortable with.
Via Christi Women's Connection presentation on advance in depression treatment by Matthew Macaluso, DO, medical director of Via Christi Psychiatric Clinic.
Psychopharmacology and Cardiovascular Disease - psycho cardiologymagdy elmasry
Psychopharmacology andCardiovascular Disease.Your Heart And Mind Are Connected.Psychiatric Disorders and Cardiovascular System .Cardiac response to acute stress .Heart disease and depression are closely linkedCardiovascular Side Effects of Psychotropic Drugs
.
Via Christi Women's Connection presentation on advance in depression treatment by Matthew Macaluso, DO, medical director of Via Christi Psychiatric Clinic.
Psychopharmacology and Cardiovascular Disease - psycho cardiologymagdy elmasry
Psychopharmacology andCardiovascular Disease.Your Heart And Mind Are Connected.Psychiatric Disorders and Cardiovascular System .Cardiac response to acute stress .Heart disease and depression are closely linkedCardiovascular Side Effects of Psychotropic Drugs
.
Pain Management in the Context of an Opioid Epidemic: Considerations and Tool...VITAS Healthcare
This presentation details how to conduct a comprehensive pain assessment, considerations when prescribing analgesics, and when opioids may be appropriate.
Presentation for our intermediate workshop in Ketamine Assisted Therapy, focusing on Somatic Work, Transpersonal Techniques, Transference, and Counter Transference.
Talk on the Healing Potential of Non Ordinary States of Consciousness, especially states elicited by the use of MDMA and Ketamine in psychedelic assisted therapy.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
2. Introduction to Ketamine-Assisted Psychotherapy
COPYRIGHT 2020
POLARIS INSIGHT CENTER – SAN FRANCISCO
.
BACKGROUND AND FUNDAMENTALS
June 11 and 13, 2020
6. Psychotherapeutic Model
• Emphasis on Set, Setting, Music, Interpersonal
Connection
• Therapeutic relationship as primary container -
physician and medicine support the psychotherapy
• Preparation and Integration built into treatment
plan
• Non-Ordinary States of Consciousness are held as
crucial for healing and seen as meaningful
• 3-hour sessions allow for plenty of time to process
material
11. Ketamine’s Signature 1/2
• Rapid onset, Rapid metabolism & Excellent safety profile
• Dose-related access/flexibility for therapeutic process – Psycholytic &
Psychedelic
• Reduction/Elimination of external stimuli and sensations &
heightening of internal visual experience
• Preservation of the observer self -observing ego - witnessing self
• Outside of bounded time and space – different levels and depth of
altered state experience
12. Ketamine’s Signature 2/2
• Spaciousness of mind, Freedom of mind, Sense of movement and
music essential in the experience
• Reduction of verbal thinking and processing and connection to
symbolic realm of experience
• Reduction in negative, obsessive, and self-referential thinking
• Experience of surrender, formlessness, love, interconnectedness,
humility, awe, gratitude and union with Divine Love, Divine Mind
• NDE, OBE, Archetypal Experiences/Encounters
• Navigating the range of ecstatic to challenging experiences
14. Neurobiological Mechanisms of Action 1/2
• Increased Glutamate Ketamine is an NMDA glutamate receptor antagonist: transmission
–prefrontal cortex
• “Master Switch:” Glutamate - most abundant and important excitatory neurotransmitter,
aka “Workhorse of the Brain”
• Glutamate Roles: Pain, Anxiety, Inflammation, Stress, Fear Conditioning, Depression,
Neurological/Psychological Resilience, Learning, Memory
• Changes in cell signaling, synaptic plasticity and strengthens neural circuitry
15. Neurobiological Mechanisms of Action 2/2
• Reverses Neuronal Atrophy
• Supports Synaptogenesis & dendrite spine morphogenesis
• Strengthens synaptic connections – learning/memory consolidation
• Reduces brain activity in areas involved in rumination and self-monitoring
• Disrupts DNF (default mode network), creates hyper-connectivity
• Regulates downstream to other neurotransmitter systems
16. This Photo by Unknown Author is licensed under CC BY-SA
This Photo by Unknown Author is licensed under CC BY-SA
17. •War on Drugs/Disinformation vs. Psychedelic Research/Practice
•Big Pharma vs. Little Pharma vs non-profit (Healthcare, Insurance)
•Ketamine World: Anesthesiology vs. Psychiatry (K infusion vs. KAP)
•Psychedelic World: Underground vs. Credentialed Professionals
•Biological- Psychological - Shamanic/Transpersonal Models
•Medical vs. Nonmedical Practitioners vs. Multi-modal tx protocols
•Addiction Issue: safety, efficacy, prevention/management
18. • Neurotoxicity Issue - safety vs. risk management vs. disinformation
• Goals of Tx: Symptom relief, personality/character change, life quality
• Relevance of standard clinical measurements for transformational Tx
• Training psychedelic therapists with/without direct experience?
• Drug regulation/restriction criminalization, incarceration- versus drug
education and personal freedom, consciousness freedom
• Essence of Healing? - molecule vs. relationship vs. both
• Changed Role of the Therapist and Role of the Patient
19. •Role and value of pleasure, awe, wonder in healing
•Role, value and risks of physical touch and contact
•Significance of dissociative, mystical, transpersonal experiences in tx
•Racial, ethnic, economic divisions regarding ACCESS and availability
•Cultural appropriation vs. Cultural honoring in treatment protocols
•The worried well vs, the Psychologically distressed - is it kosher?
•Psychedelic Naivete, Psychedelic Narcissism, Psychedelic Fascism
21. Psychological
Intake and Screening
• Psychological Testing:
• PHQ-9
• GAD-7
• PCL-5
• ACE
• BDI-II
• Change of State (after treatment)
• Resiliency
• MEQ, EDI (after treatment)
22. CHALLENGES AND CONTRAINDICATIONS
Medical Contraindications
Psychological Contraindications
Not sufficient preparation
Resistance to Integration
Not wanting to let go
Not wanting to face the problems
Not adequate collaboration with
other providers of the patient
23. Treatment Approaches
Low Dose
◇ Empathogenic Experience - Trance-like
state
◇ Psycholytic Therapy
◇ Allows for ongoing communication
◇ Induces mild dissociation, mildly
anesthetic, yet present and relaxed state
◇ Generally low-risk; low side effects
Moderate to High Dose
◇ Out of Body Experience (OBE)
◇ Near-Death Experience (NDE)
◇ Ego-Dissolving Transcendental experience
◇ Moderate to profound dissociative sedation, may be
similar to high dose classical psychedelics
◇ Potential for side effects; not suitable for all clients
24. Empathogenic
Psycholytic
Out of Body Experience
Trance
Perinatal Matrices
Near Death Experience
Ego Dissolution
Moderate Dose
High Dose
Low Dose
26. • Office relationship with Koshland Pharmacy
• Introduces patients to KAP while minimizing medical
invasiveness
• Allows for at-home use in some patients
• Empowers patients in their own healing
• Can be used in conjunction with IM administration
Sublingual Lozenges and Troches
27. • Active collaboration between physician, therapist, and patient
• Better tolerated by some patients – less side effects
• Allows for more precise dosing and stacked dosing
INTRAMUSCULAR
28. Medical Intake
and Screening
• Collaborative - Physician,
Therapist, & Patient
• Review medical history and
medications and screen for
contraindications
• Education about safety of
ketamine and drug interactions
• Answer patient’s questions
30. KETAMINE RISKS
and SIDE EFFECTS
• Nausea and Vomiting
• Transient increase in BP and heart rate
• Dizziness, disorientation, blurred vision,
headache, dry mouth
• Increase or decrease in energy (fatigue or
restlessness) (rare)
• Neurotoxicity- only in chronic and high
dose usage
• Potential for tolerance & abuse and
dependence
• Urethral cystitis and bladder pain with
chronic and long term use
• Non-compliance
31. Safety and Monitoring
• Logging medication
• Medication cabinet
• CURES
• In-office visit required for medical
evaluation
• Emergency Medical Response Plan
• Rescue medications
32. Addiction
• Ketamine can be
psychologically addictive
• No evidence of physical
dependence, but withdrawal is
possible
33. Risk management
• Patients required to
communicate with therapist
after every at-home session
• No automatic refills
• Prescribing limited number
of lozenges for trial period
• Lozenges - difficult to abuse
43. MAJOR GOALS OF KAP INTEGRATION (1)
●Safety/stabilization: Smooth re-entry, prevention, ongoing monitoring
●Attachment: Relationship continuity and repair & deepen collaboration
●Enhanced self-monitoring: Observing ego, neutrality, disentanglement
●Debriefing: Emotional processing, meaning- making, releasing, grieving
●Resolving: Pathogenic beliefs and conflicts among parts of the self
●Durability: Accrual of benefit & consolidation of gains
44. MAJOR GOALS of INTEGRATION (2)
• Dedicated application of new found wisdom; support behavior
changes
• Understanding challenging experiences: psychological &
archetypal/spiritual
• Effective use of transference and countertransference experience
• Coping with changes in identity and worldview and social system
• Process traumatic memories & meanings, and navigate spiritual
emergency
• Improved navigation of interpersonal challenges and intimacy
45. Future
Training
Opportunities
• Intermediate KAP Webinars on
6/20, 7/11, 8/15
• Advanced KAP Webinar for
practicing providers
• Experiential Trainings in fall
2020; dates TBD after COVID-19
safety is established
• Polaris Intensive KAP Retreats
in late 2020; dates TBD
46. Polaris Insight Center
4257 18th St.
San Francisco, CA 94114
415.800.7083
polarisinsight.com
info@polarisinsight.com
harvey@polarisinsight.com
eric@polarisinsight.com
veronika@polarisinsight.com
THANK YOU